Table 2

Adjusted 3-Year Clinical Outcomes According to Renal Function

CrCl ≥60 ml/min (Reference Group)CrCl 45–59 ml/minCrCl <45 ml/minp Value for Trend
Death1.001.12 (0.77–1.64)2.67 (1.85–3.85)<0.01
Cardiac death1.001.40 (0.84–2.35)2.75 (1.65–4.61)<0.01
Myocardial infarction1.000.95 (0.66–1.38)1.33 (0.90–1.97)<0.01
TLR1.000.79 (0.54–1.15)0.95 (0.62–1.45)0.56
Definite or probable ST1.000.91 (0.42–1.99)1.54 (0.70–3.39)0.05
Death or MI1.001.01 (0.76–1.33)1.91 (1.44–2.52)<0.01
Death, MI, or ST1.000.98 (0.74–1.29)1.85 (1.40–2.44)<0.01
MACE1.000.94 (0.75–1.19)1.56 (1.23–1.98)<0.01

Values are hazard ratio (95% confidence interval) unless otherwise indicated.

MACE = major adverse cardiac event(s); ST = stent thrombosis; TLR = target lesion revascularization; other abbreviations as in Table 1.